对利妥昔单抗有反应的难治性经典型获得性大疱性表皮松解症 - Suppr

Suppr

超能文献

Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab.

作者信息

Sadler E, Schafleitner B, Lanschuetzer C, Laimer M, Pohla-Gubo G, Hametner R, Hintner H, Bauer J W

出版信息

Br J Dermatol. 2007 Aug;157(2):417-9. doi: 10.1111/j.1365-2133.2007.08048.x. Epub 2007 Jun 26.

DOI:10.1111/j.1365-2133.2007.08048.x

PMID:17596155

Abstract

摘要

相似文献

Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab.对利妥昔单抗有反应的难治性经典型获得性大疱性表皮松解症

Br J Dermatol. 2007 Aug;157(2):417-9. doi: 10.1111/j.1365-2133.2007.08048.x. Epub 2007 Jun 26.

A successful therapeutic trial of rituximab in the treatment of a patient with recalcitrant, high-titre epidermolysis bullosa acquisita.利妥昔单抗治疗一名顽固性、高滴度获得性大疱性表皮松解症患者的成功治疗试验。

Br J Dermatol. 2007 Jan;156(1):194-6. doi: 10.1111/j.1365-2133.2006.07596.x.

Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximab.大疱性类天疱疮后获得性大疱性表皮松解症，用抗CD20单克隆抗体利妥昔单抗成功治疗。

Dermatology. 2007;215(3):252-5. doi: 10.1159/000106585.

Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab.使用抗CD20抗体利妥昔单抗成功辅助治疗顽固性获得性大疱性表皮松解症。

Arch Dermatol. 2006 Feb;142(2):147-50. doi: 10.1001/archderm.142.2.147.

Refractory epidermolysis bullosa acquisita: successful treatment with rituximab.难治性获得性大疱性表皮松解症：利妥昔单抗治疗成功

Clin Exp Dermatol. 2009 Dec;34(8):e979-80. doi: 10.1111/j.1365-2230.2009.03608.x.

Management of epidermolysis bullosa acquisita.获得性大疱性表皮松解症的治疗。

Dermatol Clin. 2011 Oct;29(4):643-7. doi: 10.1016/j.det.2011.06.020. Epub 2011 Aug 15.

[Successful use of combined corticosteroids and rituximab in the treatment of recalcitrant epidermolysis bullosa acquisita].[联合使用皮质类固醇和利妥昔单抗成功治疗顽固性获得性大疱性表皮松解症]

Ann Dermatol Venereol. 2009 Nov;136(11):795-9. doi: 10.1016/j.annder.2009.02.007. Epub 2009 Jun 26.

Fatal Pseudomona pneumonia following rituximab therapy in a patient with epidermolysis bullosa acquisita.一名获得性大疱性表皮松解症患者在接受利妥昔单抗治疗后发生致命性假单胞菌肺炎。

J Eur Acad Dermatol Venereol. 2007 Sep;21(8):1141-2. doi: 10.1111/j.1468-3083.2006.02127.x.

Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies).重症机械性大疱性获得性大疱性表皮松解症对免疫吸附联合利妥昔单抗（抗CD20单克隆抗体）治疗的临床反应

Arch Dermatol. 2007 Feb;143(2):192-8. doi: 10.1001/archderm.143.2.192.

A case of recalcitrant epidermolysis bullosa acquisita responsive to rituximab therapy.1例对利妥昔单抗治疗有效的顽固性获得性大疱性表皮松解症病例。

Pediatr Dermatol. 2014 Mar-Apr;31(2):241-4. doi: 10.1111/pde.12006. Epub 2012 Oct 29.

引用本文的文献

Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review.利妥昔单抗治疗获得性大疱性表皮松解症：一项系统评价。

J Clin Aesthet Dermatol. 2024 Jul;17(7):24-36.

Case Report: Biological treatment of epidermolysis bullosa acquisita: report on four cases and literature review.病例报告：获得性大疱性表皮松解症的生物治疗：四例报告及文献复习。

Front Immunol. 2023 Jul 12;14:1214011. doi: 10.3389/fimmu.2023.1214011. eCollection 2023.

Off-Label Uses of Rituximab in Dermatology.利妥昔单抗在皮肤科的非标签使用

Curr Dermatol Rep. 2022;11(4):209-220. doi: 10.1007/s13671-022-00375-4. Epub 2022 Oct 6.

Current and Innovated Managements for Autoimmune Bullous Skin Disorders: An Overview.自身免疫性大疱性皮肤病的当前及创新管理：概述

J Clin Med. 2022 Jun 19;11(12):3528. doi: 10.3390/jcm11123528.

Epidermolysis bullosa acquisita as an adverse effect from rituximab therapy: A case report.获得性大疱性表皮松解症作为利妥昔单抗治疗的不良反应：一例报告。

Medicine (Baltimore). 2020 Dec 4;99(49):e23496. doi: 10.1097/MD.0000000000023496.

Ocular Manifestations and Management of Autoimmune Bullous Diseases.自身免疫性大疱性疾病的眼部表现与治疗

J Ophthalmic Vis Res. 2019 Apr-Jun;14(2):195-210. doi: 10.4103/jovr.jovr_86_18.

Targeted Therapies for Autoimmune Bullous Diseases: Current Status.自身免疫性大疱性疾病的靶向治疗：现状。

Drugs. 2018 Oct;78(15):1527-1548. doi: 10.1007/s40265-018-0976-5.

Shifting Focus in the Therapeutics of Immunobullous Disease.免疫性大疱性疾病治疗的重点转移

Indian J Dermatol. 2017 May-Jun;62(3):282-290. doi: 10.4103/ijd.IJD_199_17.

Rituximab therapy in pemphigus and other autoantibody-mediated diseases.利妥昔单抗在天疱疮及其他自身抗体介导疾病中的治疗应用。

F1000Res. 2017 Jan 27;6:83. doi: 10.12688/f1000research.9476.1. eCollection 2017.

Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita.获得性大疱性表皮松解症的临床表现、发病机制、诊断及治疗

ISRN Dermatol. 2013 Jul 15;2013:812029. doi: 10.1155/2013/812029. eCollection 2013.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验